Yungjin Pharm. Co., Ltd. announced a private placement of series 1 bearer-bearing interest-bearing unsecured private placement convertible bonds for the gross proceeds of KRW 30,300,000,000 on November 17, 2023. The bonds carry a coupon rate of 0% and maturity rate of 2% and will mature on November 21, 2028.

The bonds are fully convertible into 13,145,336 common shares at a conversion value of KRW 2,305 per share from November 21, 2024 to October 21, 2028. The bonds are restricted to a hold period of 1 year from the date of bond issuance. The transaction will include participation from new investors Solon New Technology Association No.

10 for KRW 1,000,000,000, Shinhan Investment & Securities Co., Ltd. for KRW 2,000,000,000, KB Securities Co., Ltd. for KRW 8,400,000,000, DB Financial Investment Co., Ltd. for KRW 1,000,000,000, Hanwha Investment & Securities Co., Ltd. for KRW 1,000,000,000, Samsung Securities Co., Ltd. for KRW 6,500,000,000, NH Investment & Securities Co., Ltd. for KRW 500,000,000, Mirae Asset Securities Co., Ltd. for KRW 2,100,000,000, Hana Bank Co., Ltd. for KRW 3,000,000,000, Korea Investment & Securities Co., Ltd. for KRW 4,800,000,000. The transaction has been approved by the shareholders of the company. The transaction is expected to close on November 21, 2023.